March 2020—Oxford Gene Technology launched its SureSeq CLL + CNV Panel, a next-generation sequencing panel designed to detect 12 key genes and five chromosomal regions implicated in chronic lymphocytic leukemia progression.
The panel offers copy number variation detection, including trisomy 12 and loss of heterozygosity, as well as somatic variants, even at low allele frequency. It can detect small and large CNVs at 10 percent minor allele frequency, SNVs, and indels down to one percent minor allele frequency and loss of heterozygosity at 5–10 Mb.
Oxford Gene Technology, 914-467-5285